UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

The Different Impact of BRCA Mutations on the Survival of Epithelial Ovarian Cancer Patients: A Retrospective Single-Center Experience

Oncology, 2013-01, Vol.85 (2), p.122-127

2013

Volltextzugriff (PDF)

The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk

Journal of experimental & clinical cancer research, 2002-09, Vol.21 (3 Suppl), p.115-124

2002

Volltextzugriff (PDF)

CARCINOMA OF the VULVA: PROGNOSTIC VALUE OF the LYMPH NODE METASTASES

International journal of gynecological cancer, 2007-07, Vol.17 (4), p.946-946

2007

Volltextzugriff (PDF)

00047 FIVER II VERSUS FIVER III NERVE SPARING RADICAL HYSTERECTOMY: COMPARISON OF LOWER URINARY TRACT DYSFUNCTIONS AND MORBIDITY

International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.64-64

2005

Volltextzugriff (PDF)

High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer

Annals of oncology, 1993-01, Vol.4 (1), p.55-61

1993

Volltextzugriff (PDF)

Recovering optic neuritis during systemic cisplatin and carboplatin chemotherapy

Acta neurologica Scandinavica, 1997-10, Vol.96 (4), p.260-261

1997

Volltextzugriff (PDF)

BMRI in early detection of breast cancer in patients with increased genetic risk: our preliminary results

Journal of experimental & clinical cancer research, 2002-09, Vol.21 (3 Suppl), p.125-130

2002

Volltextzugriff (PDF)

Atypical Epithelial Proliferation in Fallopian Tubes in Prophylactic Salpingo-oophorectomy Specimens from BRCA1 and BRCA2 Germline Mutation Carriers

International journal of gynecological pathology, 2004-01, Vol.23 (1), p.35-40

2004

Volltextzugriff (PDF)

Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer

Cancer chemotherapy and pharmacology, 1990-01, Vol.25 (5), p.355-360

1990

Volltextzugriff (PDF)

A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy, in advanced ovarian carcinoma

Cancer research (Chicago, Ill.), 1996-02, Vol.56 (4), p.689-693

1996

Volltextzugriff (PDF)

Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online

Human mutation, 1998, Vol.12 (3), p.215-215

1998

Volltextzugriff (PDF)

A preoperative single course of high-dose cisplatin and bleomycin with glutathione protection in bulky stage IB/II carcinoma of the cervix

Annals of oncology, 1992-02, Vol.3 (2), p.117-121

1992

Volltextzugriff (PDF)

Gene expression of DNA topoisomerases I, IIα and IIβ and response to cisplatin‐based chemotherapy in advanced ovarian carcinoma

International journal of cancer, 1996-08, Vol.67 (4), p.479-484

1996

Volltextzugriff (PDF)

An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosis

European journal of cancer (1990), 1995-12, Vol.31 (13), p.2248-2254

1995

Volltextzugriff (PDF)

Glutathione and detoxification

Cancer treatment reviews, 1990-09, Vol.17 (2), p.203-208

1990

Volltextzugriff (PDF)

Peripheral neurotoxicity following high-dose cisplatin with glutathione: clinical and neurophysiological assessment

Tumori, 1992-08, Vol.78 (4), p.253

1992

Volltextzugriff (PDF)

Gemcitabine combined with oxaliplatin (GEMOX) as second-line chemotherapy in patients with advanced ovarian cancer refractory or resistant to platinum and taxane: A multicentric feasibility study

Oncology, 2004, Vol.67 (5-6), p.376-381

2004

Volltextzugriff (PDF)

First-line chemotherapy with intraperitoneal cisplatin and intravenous cyclophosphamide in ovarian carcinoma: a preliminary report

American journal of clinical oncology, 1989-04, Vol.12 (2), p.118-122

1989

Volltextzugriff (PDF)

A feasibility study of cisplatin administration with low-volume hydration and glutathione protection in the treatment of ovarian carcinoma

Anticancer research, 1991-07, Vol.11 (4), p.1613

1991

Volltextzugriff (PDF)

Microinvasive squamous cell cervical carcinoma

Critical reviews in oncology/hematology, 2003-12, Vol.48 (3), p.251-261

2003

Volltextzugriff (PDF)

Nerve-sparing radical hysterectomy: a pilot study

Tumori, 2003-09, Vol.89 (5), p.497-501

2003

Volltextzugriff (PDF)

The intramuscular administration of granulocyte colony-stimulating factor as an adjunct to chemotherapy in pretreated ovarian cancer patients: an Italian Trials in Medical Oncology (ITMO) Group pilot study

British journal of cancer, 1994-05, Vol.69 (5), p.961-966

1994

Volltextzugriff (PDF)

An intensive treatment with mitoxantrone and ifosfamide in second-line therapy of epithelial ovarian cancer

Tumori, 1994-12, Vol.80 (6), p.443

1994

Volltextzugriff (PDF)

Mitoxantrone and ifosfamide as second-line therapy of epithelial ovarian cancer. a pilot study by the I.T.M.O. group

European journal of cancer (1990), 1994, Vol.30 (14), p.2188-2188

1994

Volltextzugriff (PDF)

Color-Doppler ultrasound in ovarian masses: anatomo-pathologic correlation

Tumori, 1993-08, Vol.79 (4), p.262

1993

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Female
(36)
Humans
(36)
Science & Technology
(34)
Life Sciences & Biomedicine
(32)
Oncology
(30)
Middle Aged
(27)
Adult
(23)
Ovarian Neoplasms - Drug Therapy
(18)
Aged
(17)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Ovarian Neoplasms - Pathology
(12)
Pharmacology. Drug Treatments
(12)
Cisplatin - Administration & Dosage
(11)
Neoplasm Staging
(11)
Antineoplastic Agents
(10)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(9)
Prognosis
(9)
Chemotherapy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Different Impact of BRCA Mutations on the Survival of Epithelial Ovarian Cancer Patients: A Retrospective Single-Center Experience

The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk

CARCINOMA OF the VULVA: PROGNOSTIC VALUE OF the LYMPH NODE METASTASES

00047 FIVER II VERSUS FIVER III NERVE SPARING RADICAL HYSTERECTOMY: COMPARISON OF LOWER URINARY TRACT DYSFUNCTIONS AND MORBIDITY

High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer

Recovering optic neuritis during systemic cisplatin and carboplatin chemotherapy

BMRI in early detection of breast cancer in patients with increased genetic risk: our preliminary results

Atypical Epithelial Proliferation in Fallopian Tubes in Prophylactic Salpingo-oophorectomy Specimens from BRCA1 and BRCA2 Germline Mutation Carriers

Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer

A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy, in advanced ovarian carcinoma

Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online

A preoperative single course of high-dose cisplatin and bleomycin with glutathione protection in bulky stage IB/II carcinoma of the cervix

Gene expression of DNA topoisomerases I, IIα and IIβ and response to cisplatin‐based chemotherapy in advanced ovarian carcinoma

An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosis

Glutathione and detoxification

Peripheral neurotoxicity following high-dose cisplatin with glutathione: clinical and neurophysiological assessment

Gemcitabine combined with oxaliplatin (GEMOX) as second-line chemotherapy in patients with advanced ovarian cancer refractory or resistant to platinum and taxane: A multicentric feasibility study

First-line chemotherapy with intraperitoneal cisplatin and intravenous cyclophosphamide in ovarian carcinoma: a preliminary report

A feasibility study of cisplatin administration with low-volume hydration and glutathione protection in the treatment of ovarian carcinoma

Microinvasive squamous cell cervical carcinoma

Nerve-sparing radical hysterectomy: a pilot study

The intramuscular administration of granulocyte colony-stimulating factor as an adjunct to chemotherapy in pretreated ovarian cancer patients: an Italian Trials in Medical Oncology (ITMO) Group pilot study

An intensive treatment with mitoxantrone and ifosfamide in second-line therapy of epithelial ovarian cancer

Mitoxantrone and ifosfamide as second-line therapy of epithelial ovarian cancer. a pilot study by the I.T.M.O. group

Color-Doppler ultrasound in ovarian masses: anatomo-pathologic correlation

Suchergebnisse filtern